Cholesterol Absorption Inhibitors
Links shared publicly online about this topic
Support for CETP inhibitors
theheart.org — “A new analysis has found that common variants in the gene coding for cholesterol ester transfer protein have an impact on the future risk of MI and that this association is partly but not fully mediated via effects on baseline HDL-C. The results support continued investigation of agents that target CETP as a potential method for vascular risk reduction, say the researchers. (Ridker PM et al. Circ Cardiovasc Genet; published online before print January 23, 2009.)” View full resource at theheart.org
Most Recently Shared on January 29, 2009 at 8:33 pm By:
Variants at CETP locus affect future risk of MI http://tinyurl.com/cwr44l
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - Topix
topix.com — “Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - Topix” View full resource at topix.com
Most Recently Shared on March 25, 2012 at 7:02 pm By:
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study http://t.co/LE9KaWT1
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: THOUSAND OAKS, Calif., March 25, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN - News) announced today positive results from a Phase 1b clinical study of AMG 145, an investigational PCSK9 inhibitor, in patients with ...” View full resource at finance.yahoo.com
Most Recently Shared on March 25, 2012 at 8:04 pm By:
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study: THOUSAND OAKS, Calif., March... http://t.co/0yI7WIR9
Family Med Medical News about Cholesterol Vegetables Intestinal Absorption
mdlinx.com — “When cholesterol is not cholesterol: A note on the enzymatic determination of its concentration in model systems containing vegetable extracts” View full resource at mdlinx.com
Most Recently Shared on June 22, 2010 at 6:18 pm By:
When cholesterol is not cholesterol: A note on the enzymatic determination of its concentration in mode... http://bit.ly/bvg9Zd #GM #mdlinx
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA
jama.ama-assn.org — “Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on November 15, 2011 at 1:14 pm By:
New medication increases HDL and decreases LDL cholesterol levels. Paper presented at #AHA11 and JAMA publishes online: http://t.co/G7KmRwhu
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA
jama.ama-assn.org — “Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol, November 16, 2011, Nicholls et al. 306 (19): 2099 — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on November 21, 2011 at 4:49 pm By:
Cholesterol Ppt Powerpoint Presentation slides Dr. H S Medical Slideshow inhibit cholesterol absorption sterols displace cholesterol on chylomicron
slideworld.org — “Powerpoint Cholesterol Slides by Dr. H S inhibit cholesterol absorption sterols displace cholesterol on chylomicron Download Free Medical Powerpoint Presentations” View full resource at slideworld.org
Most Recently Shared on September 25, 2009 at 6:47 am By:
Cholesterol : Cholesterol,high cholesterol,cholesterol diet,low cholesterol,cholesterol foods,cholesterol test,.. http://bit.ly/WyeGj
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch
marketwatch.com — “Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on March 26, 2012 at 12:15 pm By:
Amgen's PCSK9 Inhibitor Reduced LDL Cholesterol up to 81 Percent in Phase 1b Study - MarketWatch http://t.co/JegMV1XV
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System - Forbes
forbes.com — “The American College of Cardiology (ACC) meeting is in full swing this week in Chicago and much of the early buzz being generated is around a new class of LDL cholesterol-lowering drugs known as proprotein converase subtilisin/kexin type 9 (PCSK-9) antibodies. Inhibitors of PCSK-9 have been pursued for almost a [...]” View full resource at forbes.com
Most Recently Shared on March 26, 2012 at 8:07 pm By:
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System: The American College of Cardiology (ACC) ... http://t.co/p51Irjyi
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System - Forbes
forbes.com — “The American College of Cardiology (ACC) meeting is in full swing this week in Chicago and much of the early buzz being generated is around a new class of LDL cholesterol-lowering drugs known as proprotein converase subtilisin/kexin type 9 (PCSK-9) antibodies. Inhibitors of PCSK-9 have been pursued for almost a [...]” View full resource at forbes.com
Most Recently Shared on March 26, 2012 at 5:52 pm By:
New Cholesterol-Lowering Drugs Will Test the Future Healthcare System: The American College of Cardiology ... http://t.co/YvG6SI3g #drug
The Cholesterol Bet | February 20, 2012 Issue - Vol. 90 Issue 8 | Chemical & Engineering News
cen.acs.org — “The Cholesterol Bet | February 20, 2012 Issue - Vol. 90 Issue 8 | Chemical & Engineering News” View full resource at cen.acs.org
Most Recently Shared on February 20, 2012 at 2:01 pm By:
Can firms overcome a huge cholesterol drug flop? by @carmendrahl http://t.co/ysMtp23j $PFE $MRK $LLY $RHHBY
DEFINE: Large Effects on LDL and HDL Cholesterol With CETP Inhibitor Anacetrapib - QualityPoint Technologies
qualitypointtech.net — “With the dramatic changes in LDL- and HDL-cholesterol levels and no apparent off-target blood pressure, electrolyte, and aldosterone effects, as well as no adverse safety signal that plagued torcetrapib, DEFINE investigators say larger trials with the new CETP inhibitor anacetrapib are justified. Heartwire” View full resource at qualitypointtech.net
Most Recently Shared on November 17, 2010 at 9:47 pm By:
DEFINE: Large Effects on LDL and HDL Cholesterol With CETP Inhibitor Anacetrapib: With the dramatic changes in LDL... http://bit.ly/92yCFl
Study Suggests Possibility that CETP Inhibitors May Improve Glycemic Control - Larry Husten - Cardiobrief - Forbes
blogs.forbes.com — “A new analysis of the ILLUMINATE trial raises the possibility that CETP inhibitors like torcetrapib may have the unexpected beneficial effect of improving glycemic control in addition to their intended effect of raising HDL cholesterol. Development of torceptrapib was halted several years ago following the early termination of the large [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 18, 2011 at 8:32 pm By:
Study Suggests Possibility that CETP Inhibitors May Improve Glycemic Control: A new analysis of the ILL... http://onforb.es/pMKsQI #drug
Proton Pump Inhibitors on #MDlinx
mdlinx.com — “Proton Pump Inhibitors on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 4, 2010 at 7:50 pm By:
Association of Long-Term Proton Pump Inhibitor Therapy with Bone Fractures and Effects on Absorption of C... http://bit.ly/dlJlVx #medicine
Podcast: Overuse of proton pump inhibitors, food allergies, benefit of fibrates, nut consumption/cholesterol levels: http://bit.ly/cPzeos
hopkinsmedicine.org — “Podcast: Overuse of proton pump inhibitors, food allergies, benefit of fibrates, nut consumption/cholesterol levels: http://bit.ly/cPzeos” View full resource at hopkinsmedicine.org
Most Recently Shared on May 14, 2010 at 3:47 pm By:
Podcast: Overuse of proton pump inhibitors, food allergies, benefit of fibrates, nut consumption/cholesterol levels: http://bit.ly/cPzeos
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Cary Byrd - eDrugSearch.com
I run a comparison shopping engine and social network for prescription-drug buyers. We regularly post drug news and money-saving tips on our blog.
-
Cholesterol OW
Organizing cholesterol resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement

